In the exploration of cancer treatment modalities, an article published in Biomolecules and Biomedicine titled "CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar," offers an examination ...
Jan 17, 2024
0
1
Internet-based cognitive behavioral therapy (CBT) for depression is often just as effective as traditional CBT. This is clear from an international study involving scientists at the University of Gothenburg. However, some ...
Aug 2, 2021
0
70
In spite of many clinical options, people with mental health problems including eating disorders often do not access professional help within the crucial first 12 months—in part because of lack of information in the community ...
Jul 9, 2021
0
2
Sleep disturbances are a frequent complaint of women in the menopause transition and postmenopause. A new study demonstrates that women with premature ovarian insufficiency (POI) who are receiving hormone therapy have poorer ...
Jul 16, 2019
0
10
An increasing number of new anti-cancer drugs are approved each year. During the authorization process, such new drugs usually undergo comparisons to other single drugs, but only rarely to multiple established drugs. This ...
Feb 14, 2019
0
0
(HealthDay)—There are considerable gaps in knowledge relating to the effectiveness of non-pharmacologic treatments for attention-deficit/hyperactivity disorder (ADHD) in pediatric patients, according to a review published ...
Jun 2, 2018
0
5
The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to address the selection of specific categories of devices when endovascular therapy (EVT) is indicated. The purpose of this ...
Apr 25, 2018
0
3
In non-small cell lung cancer (NSCLC) that has already formed metastases, the suitable treatment depends, among other factors, on the genes that are activated in the tumour cells and whether mutations have occurred that make ...
May 15, 2017
0
0
The drug combination sofosbuvir/velpatasvir (trade name: Epclusa) has been approved since July 2016 for the treatment of patients with chronic hepatitis C (CHC). In an early benefit assessment, the German Institute for Quality ...
Oct 17, 2016
0
1
The monoclonal antibody elotuzumab has been approved in combination with lenalidomide and dexamethasone since May 2016 for further treatment of multiple myeloma in adults who have received at least one previous treatment. ...
Sep 1, 2016
0
1
